https://www.selleckchem.com/products/OSI-906.html
Mechanistically, circZFR bound with SSBP1, thereby promoting the assembly of CDK2/cyclin E1 complexes. The activation of CDK2/cyclin E1 complexes induced p-Rb phosphorylation, thus releasing activated E2F1 leading to cell cycle progression and cell proliferation. Our findings provide the first evidence that circZFR is a novel onco-circRNA and might be a potential biomarker and therapeutic target for cervical cancer patients. Our findings provide the first evidence that circZFR is a novel onco-circRNA and might be a potential biomarker a
Like
Comment
Share
